Clinical trials
Completed Phase 3 trials in Zimbabwe
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
28 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2002 | 1 |
| 2004 | 1 |
| 2005 | 1 |
| 2006 | 1 |
| 2007 | 1 |
| 2010 | 1 |
| 2011 | 2 |
| 2012 | 4 |
| 2013 | 2 |
| 2015 | 1 |
| 2016 | 4 |
| 2017 | 1 |
| 2018 | 2 |
| 2019 | 1 |
| 2020 | 2 |
| 2021 | 1 |
| 2023 | 1 |
| 2024 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 28 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| National Institute of Allergy and Infectious Diseases (NIAID) | 8 |
| Advancing Clinical Therapeutics Globally for HIV/AIDS and Other Infections | 4 |
| International Partnership for Microbicides, Inc. | 2 |
| University of Zimbabwe | 2 |
| AIDS Malignancy Consortium | 1 |
| Anna Griffiths, MRC | 1 |
| Centers for Disease Control and Prevention | 1 |
| Justine Boles | 1 |
| London School of Hygiene and Tropical Medicine | 1 |
| Ministry of Health and Child Welfare, Zimbabwe | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| HIV Infections | 14 |
| Acquired Immunodeficiency Syndrome | 3 |
| Postpartum Hemorrhage | 2 |
| Tuberculosis | 2 |
| Atrial Fibrillation | 1 |
| COVID-19 | 1 |
| Cardiovascular Diseases | 1 |
| Child Nutrition Disorders | 1 |
| Inflammation | 1 |
| Influenza, Human | 1 |
Trials
Showing 1 to 25 of 28. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.